<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1608-8921</journal-id>
<journal-title><![CDATA[Gaceta Médica Espirituana]]></journal-title>
<abbrev-journal-title><![CDATA[Gac Méd Espirit]]></abbrev-journal-title>
<issn>1608-8921</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Sancti Spíritus]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1608-89212015000100013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Obesidad e hipertensión arterial]]></article-title>
<article-title xml:lang="en"><![CDATA[Obesity and arterial hypertension]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Miguel Soca]]></surname>
<given-names><![CDATA[Pedro Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ponce de León]]></surname>
<given-names><![CDATA[Delmis]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad de Ciencias Médicas.Holguín.Cuba  ]]></institution>
<addr-line><![CDATA[Holguín ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2015</year>
</pub-date>
<volume>17</volume>
<numero>1</numero>
<fpage>126</fpage>
<lpage>129</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1608-89212015000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1608-89212015000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1608-89212015000100013&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana, sans-serif"><b>CARTA AL EDITOR</b></font></p>     <p>&nbsp;</p>      <p align="justify"><font size="4" face="Verdana, sans-serif"><b>Obesidad e hipertensi&oacute;n arterial</b></font></p>     <p>&nbsp;</p>      <p align="justify"><font size="3" face="Verdana, sans-serif"><b>Obesity and arterial hypertension</b></font></p>     <p>&nbsp;</p>    <p>&nbsp;</p>      <p align="justify"><font size="2" face="Verdana, sans-serif"><b>Dr. Pedro Enrique Miguel Soca<sup>I</sup>, Lic. Delmis Ponce de Le&oacute;n<sup>I</sup>. </b></font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">I&nbsp;Universidad de Ciencias M&eacute;dicas.Holgu&iacute;n.Cuba.    <br> </font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>    <p>&nbsp;</p> <hr noshade size=1 />     <p align="justify"><font size="2" face="Verdana, sans-serif"><b>CARTA AL EDITOR</b></font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">Sr. Editor:</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">Un reciente estudio transversal de Medina Mart&iacute;n et al.<sup>1</sup> encontr&oacute; una elevada frecuencia de antecedentes patol&oacute;gicos familiares de hipertensi&oacute;n arterial (HTA) y obesidad en m&aacute;s de 90 % de pacientes pedi&aacute;tricos con HTA, lo que coincide en parte con otros estudios realizados en Sancti Spiritus y Holgu&iacute;n <sup>2,3</sup>.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">El elevado porcentaje de HTA en familiares de estos ni&ntilde;os se explica en parte por el rol de los genes de hipertensi&oacute;n, aspecto tratado por Miguel y Ram&iacute;rez en esta revista <sup>4</sup>. Ahora nos referiremos a la asociaci&oacute;n de la obesidad con la HTA, un conocido v&iacute;nculo demostrado en diferentes estudios cl&iacute;nicos y epidemiol&oacute;gicos, con aspectos controversiales y pol&eacute;micos <sup>5-7</sup>.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">Durante la obesidad abdominal se incrementa la llegada de &aacute;cidos grasos al h&iacute;gado, lo que favorece la s&iacute;ntesis de triglic&eacute;ridos, la esteatosis hep&aacute;tica y el aumento de lipoprote&iacute;nas de muy baja densidad (VLDL); el incremento de VLDL en sangre provoca hipertrigliceridemia y una alteraci&oacute;n del patr&oacute;n de lipoprote&iacute;nas plasm&aacute;ticas con predominio de lipoprote&iacute;nas de baja densidad (LDL) y una reducci&oacute;n de lipoprote&iacute;nas de alta densidad (HDL), denominada dislipidemia aterog&eacute;nica <sup>5</sup>.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">La dislipidemia induce resistencia a la insulina (RI), un estado vinculado a una activaci&oacute;n del sistema nervioso simp&aacute;tico y al eje renina-angiotensina-aldosterona, que incrementan las cifras de presi&oacute;n arterial. Otro factor que acompa&ntilde;a a la RI y que favorece la HTA es la hiperuricemia.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">El tejido adiposo es un &oacute;rgano endocrino que sintetiza hormonas o adipoquinas que constituyen se&ntilde;ales claves en el mantenimiento de la homeostasis metab&oacute;lica, cuya disfunci&oacute;n se vincula a un amplio rango de enfermedades metab&oacute;licas como HTA <sup>8</sup>. La obesidad induce un estado inflamatorio de bajo grado por la secreci&oacute;n de citoquinas proinflamatorias y la infiltraci&oacute;n de c&eacute;lulas inmunes en el tejido adiposo.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">La obesidad abdominal puede ser determinada f&aacute;cilmente mediante el per&iacute;metro de cintura y el &iacute;ndice cintura-cadera, medidas antropom&eacute;tricas que reflejan la acumulaci&oacute;n de grasa visceral y que se asocian a un riesgo aumentado de aterosclerosis, HTA y diabetes mellitus, no valorada por los investigadores citados <sup>1</sup>. Sugerimos a Medina Mart&iacute;n et al.<sup>1</sup> en futuras investigaciones incluir en el estudio estos par&aacute;metros antropom&eacute;tricos y determinar el perfil lip&iacute;dico de los pacientes.</font></p>       ]]></body>
<body><![CDATA[<p align="justify"><font size="2" face="Verdana, sans-serif"><b>Palabras clave:</b> hipertensi&oacute;n, obesidad, ni&ntilde;os.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif"><b>DeCS:</b> HIPERTENSI&Oacute;N; OBESIDAD; NI&Ntilde;OS.</font></p> <hr noshade size=1 />     <p align="justify"><font size="2" face="Verdana, sans-serif"><b>LETTER TO THE    EDITOR</b></font></p>     <p align="justify"><font size="2" face="Verdana, sans-serif">Mr. Editor:</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">A recent cross sectional study of Medina Mart&iacute;n et al. <sup>1</sup> found an elevated frequency of a pathological family history of high blood pressure (HBP) and obesity in more than 90 % of pediatric patients with HBP. It partially agrees with other studies done in Sancti Spiritus and Holgu&iacute;n <sup>2,3</sup>.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">The high percentage of HBP in the families of these children is explained partially on the role of hypertension genes, aspect treated by Miguel and Ram&iacute;rez in this magazine <sup>4</sup>. Now, we will refer to the relationship between obesity and hypertension, a well-defined link proven in other epidemiological and clinical studies, and yet controversial <sup>5-7</sup>.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">In abdominal obesity, the arrival of fatty acids to the liver is increased. This favors triglyceride synthesis, hepatic steatosis and the increase of very low density lipoproteins (VLDL). The increase of VLDL in blood causes an alteration in the plasmatic lipoprotein pattern with predominant low density lipoprotein (LDL) and a reduction of high density lipoproteins (HDL), which is called atherogenic dyslipidemia<sup> 5</sup>.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">Dyslipidemia induces insulin resistance (IR), a state bound to the activation of the sympathetic nervous system and the renine-angiotensine-aldosterone axis, which increases blood pressure. Another factor accompanying IR, which favors HBP, is hyperuricemia.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">Adipose tissue is an endocrine organ that synthesizes hormones and adipokines which represent key signals in keeping metabolic homeostasis, whose malfunctioning is linked to a wide range of metabolic diseases such as HBP <sup>8</sup>. Obesity induces a low grade inflammatory state due to the secretion of pro-inflammatory cytokines and the infiltration of immune cells in adipose tissue.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif">Abdominal obesity can be easily determined through the waist circumference and waist to hip ratio, anthropometric measures that reflect the accumulation of visceral fat, which associate to a risk of arteriosclerosis, HBP and diabetes mellitus, not considered by the cited authors <sup>1</sup>. We suggest Medina Mart&iacute;n et al. to include anthropometric measures and to determine the lipid profile of the patients in further studies.</font></p>      ]]></body>
<body><![CDATA[<p align="justify"><font size="2" face="Verdana, sans-serif"><b>Keywords:</b>    hypertension; obesity; children.</font></p>      <p align="justify"><font size="2" face="Verdana, sans-serif"><b>MeSH:</b> HYPERTENSION; OBESITY; CHILD.</font></p> <hr noshade size=1 />     <p align="justify"><font size="3" face="Verdana, sans-serif"><b>REFERENCIAS BIBLIOGR&Aacute;FICAS</b></font></p>     <!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">1.&nbsp;Medina Mart&iacute;n AR, Hern&aacute;ndez Palacios TL, Veloso Ram&iacute;rez D, Ramos Ramos L, &Aacute;lvarez Navarro R, Valdivia Ca&ntilde;izares S. Caracter&iacute;sticas cl&iacute;nico-epidemiol&oacute;gicas de los pacientes menores de 15 a&ntilde;os con diagn&oacute;stico de hipertensi&oacute;n arterial. Gac M&eacute;d Espirit&nbsp; [Internet]. 2014&nbsp; Dic [citado&nbsp; 2015&nbsp; Ene&nbsp; 08];&nbsp; 16(3): 01-08. Disponible en: <a href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1608-89212014000300005" target="_blank">http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1608-89212014000300005</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">2.&nbsp;Medina Mart&iacute;n AR, Batista S&aacute;nchez T, Rodr&iacute;guez Borrego BJ, Chaviano Castillo M, Jim&eacute;nez Machado N, Noda Rodr&iacute;guez T. Factores de riesgo cardiovascular en adolescentes con hipertensi&oacute;n arterial esencial. Gac M&eacute;d Espirit&nbsp; [Internet]. 2014&nbsp; Ago [citado&nbsp; 2014&nbsp; Sep&nbsp; 04];&nbsp; 16(2): 64-74. Disponible en: <a href="http://scielo.sld.cu/scielo.php?pid=S1608-89212014000200008&amp;script=sci_arttext" target="_blank">http://scielo.sld.cu/scielo.php?pid=S1608-89212014000200008&amp;script=sci_arttext</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">3.&nbsp;Labarta Rodr&iacute;guez DM, Alonso Salceda K, Mart&iacute;nez Garc&iacute;a O. Factores de riesgo ateroescler&oacute;ticos en adolescentes de 12-13 a&ntilde;os. CCM [Internet]. 2013 [citado&nbsp; 2014&nbsp; Sep&nbsp; 04]; 17 (4). Disponible en: <a href="http://scielo.sld.cu/scielo.php?pid=S1560-43812013000400006&amp;script=sci_arttext" target="_blank">http://scielo.sld.cu/scielo.php?pid=S1560-43812013000400006&amp;script=sci_arttext</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">4.&nbsp;Miguel Soca PE, Ram&iacute;rez Infantes B. Factores gen&eacute;ticos en la hipertensi&oacute;n esencial. Gac M&eacute;d Espirit&nbsp; [Internet]. 2014&nbsp; Dic [citado&nbsp; 2015&nbsp; Ene&nbsp; 08];&nbsp;16(3): 01-03. Disponible en: <a href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1608-89212014000300001" target="_blank">http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1608-89212014000300001</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">5.&nbsp;Santiago Mart&iacute;nez Y, Miguel Soca PE, Ricardo Santiago A, Marrero Hidalgo MM, Pe&ntilde;a P&eacute;rez I. Caracterizaci&oacute;n de ni&ntilde;os y adolescentes obesos con s&iacute;ndrome metab&oacute;lico. Rev Cubana Pediatr&nbsp; [Internet]. 2012&nbsp; Mar [citado&nbsp; 2015&nbsp; Ene&nbsp; 08]; 84(1):1-21. Disponible en: <a href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0034-75312012000100002" target="_blank">http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0034-75312012000100002</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">6.&nbsp;Miguel Soca PE, Ni&ntilde;o Escofet S, Rodr&iacute;quez L&oacute;pez M, Almaguer Herrera A. Pesquisaje de s&iacute;ndrome metab&oacute;lico en mujeres obesas. CCM [Internet]. 2004 [citado&nbsp; 2015&nbsp; Ene&nbsp; 09];8(4) Disponible en: <a href="http://www.researchgate.net/publication/271214292_Pesquisaje_de_sndrome_metablico_en_mujeres_obesas._Screening_of_the_metabolic_syndrome_in_obese_women" target="_blank">http://www.researchgate.net/publication/271214292_Pesquisaje_de_sndrome_metablico_en_mujeres_obesas._Screening_of_the_metabolic_syndrome_in_obese_women</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">7.&nbsp;Rodr&iacute;guez Galv&aacute;n RA, Castillo Rodr&iacute;guez AE, Acosta Mart&iacute;nez T, Conde de Lara E, Conde Reboso A, Carrazana Rom&aacute;n K. Estrategia intervencionista en pacientes hipertensos de los servicios m&eacute;dicos del MININT. Gac M&eacute;d Espirit&nbsp; [Internet]. 2008&nbsp; Dic [citado&nbsp; 2015&nbsp; Ene&nbsp; 09] ;&nbsp; 10 (Supl. 1) Disponible en: <a href="http://revgmespirituana.sld.cu/index.php/gme/article/download/601/424" target="_blank">http://revgmespirituana.sld.cu/index.php/gme/article/download/601/424</a></font><!-- ref --><p align="justify"><font size="2" face="Verdana, sans-serif">8.&nbsp;Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol [Internet]. 2014 Jan [cited: 2015 jan 8] ;220(2):T47-59 Available from: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887367/" target="_blank">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887367/</a></font><p>&nbsp;</p>    <p>&nbsp;</p>     <p align="justify"><font size="2" face="Verdana, sans-serif">Recibido: 09/01/2015    <br>Aprobado: 10/02/2015</font></p>      <p>&nbsp;</p>    <p>&nbsp;</p>      <p align="justify"><font size="2" face="Verdana, sans-serif"><i>Dr.Pedro Enrique Miguel Soca.</i> Universidad de Ciencias M&eacute;dicas. Holgu&iacute;n. Cuba.</font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina Martín]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Palacios]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Veloso Ramírez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos Ramos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Navarro]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Valdivia Cañizares]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Características clínico-epidemiológicas de los pacientes menores de 15 años con diagnóstico de hipertensión arterial]]></article-title>
<source><![CDATA[Gac Méd Espirit]]></source>
<year>2014</year>
<month> D</month>
<day>ic</day>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>01-08</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina Martín]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Batista Sánchez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Borrego]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chaviano Castillo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Machado]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Noda Rodríguez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo cardiovascular en adolescentes con hipertensión arterial esencial]]></article-title>
<source><![CDATA[Gac Méd Espirit]]></source>
<year>2014</year>
<month> A</month>
<day>go</day>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>64-74</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Labarta Rodríguez]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso Salceda]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez García]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo ateroescleróticos en adolescentes de 12-13 años]]></article-title>
<source><![CDATA[CCM]]></source>
<year>2013</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miguel Soca]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez Infantes]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Factores genéticos en la hipertensión esencial]]></article-title>
<source><![CDATA[Gac Méd Espirit]]></source>
<year>2014</year>
<month> D</month>
<day>ic</day>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>01-03</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santiago Martínez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Miguel Soca]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Ricardo Santiago]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Marrero Hidalgo]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Peña Pérez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Caracterización de niños y adolescentes obesos con síndrome metabólico]]></article-title>
<source><![CDATA[Rev Cubana Pediatr]]></source>
<year>2012</year>
<month> M</month>
<day>ar</day>
<volume>84</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-21</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miguel Soca]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Niño Escofet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríquez López]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Almaguer Herrera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Pesquisaje de síndrome metabólico en mujeres obesas]]></article-title>
<source><![CDATA[CCM]]></source>
<year>2004</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Galván]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo Rodríguez]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta Martínez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Conde de Lara]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Conde Reboso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carrazana Román]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Estrategia intervencionista en pacientes hipertensos de los servicios médicos del MININT]]></article-title>
<source><![CDATA[Gac Méd Espirit]]></source>
<year>2008</year>
<month> D</month>
<day>ic</day>
<volume>10</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Adipocytokines in obesity and metabolic disease]]></article-title>
<source><![CDATA[J Endocrinol]]></source>
<year>2014</year>
<month> J</month>
<day>an</day>
<volume>220</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>T47-59</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
